1. June CH. Chapter 30—adoptive cellular therapy with synthetic T cells as an “Instant Vaccine” for cancer and immunity. In: Bloom BR, Lambert P-H, ediorss. The vaccine book. 2nd ed. Academic Press; 2016. p. 581–596.
2. Lundh S, Jung IY, Dimitri A, et al. Clinical practice: chimeric antigen receptor (CAR) T cells: a major breakthrough in the battle against cancer. Clin Exp Med. 2020;20(4):469–80.
3. National Cancer Institute, Surveillance, Epidemiology and End Results Program. Cancer Stat Facts: Non-Hodgkin Lymphoma. https://seer.cancer.gov/statfacts/html/nhl.html. Accessed 31 Mar 2021.
4. Richardson A, Apaydin E, Baxi S, et al. Landscape review and evidence map of gene therapy, part II: Chimeric Antigen Receptor-T cell (CAR-T), autologous cell, antisense, RNA interference (RNAi), Zinc Finger Nuclease (ZFN), genetically modified oncolytic herpes virus. Washington, DC: Patient-Centered Outcomes Research Institute (PCORI); 2019.
5. Richardson A, Apaydin E, Baxi S, et al. Landscape review and evidence map of gene therapy, part I: adenovirus, adeno-associated virus, and clustered regularly interspaced short palindromic repeats. Washington, DC: Patient-Centered Outcomes Research Institute (PCORI); 2019.